NASDAQ:OCEA - Nasdaq - US67644C1045 - Common Stock - Currency: USD
0.1
0 (-0.6%)
The current stock price of OCEA is 0.1 USD. In the past month the price decreased by -47.23%. In the past year, price decreased by -95%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 20.66 | 369.39B | ||
AMGN | AMGEN INC | 15.54 | 165.43B | ||
GILD | GILEAD SCIENCES INC | 24.8 | 142.43B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1654.45 | 123.26B | ||
REGN | REGENERON PHARMACEUTICALS | 15.31 | 76.39B | ||
ARGX | ARGENX SE - ADR | 242.12 | 37.96B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 31.83B | ||
ONC | BEIGENE LTD-ADR | N/A | 29.00B | ||
BNTX | BIONTECH SE-ADR | N/A | 27.07B | ||
NTRA | NATERA INC | N/A | 20.54B | ||
BIIB | BIOGEN INC | 8.53 | 20.47B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 15.26B |
Ocean Biomedical, Inc. is a biopharmaceutical company. The company is headquartered in New York City, New York. The company went IPO on 2021-09-15. The firm is focused on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The firm helps to accelerates the development and commercialization of assets from research universities and medical centers. In oncology, it is engaged in developing a mono-specific and two bi-specific humanized monoclonal antibodies (mAb), product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer (NSCLC), and of glioblastoma multiforme (GBM). The company offers three product candidates based on the novel target discoveries: a malaria vaccine candidate targeting either or both of PfSEA-1, and parasite antigen PfGARP, which is referred to as its ODA-570 candidate; a humanized mAb malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-611 candidate, and a small molecule malaria therapeutic candidate targeting PfGARP, which is referred to as ODA-579 candidate.
OCEAN BIOMEDICAL INC
515 Madison Ave Suite 8078
New York City NEW YORK US
Employees: 9
Company Website: https://www.oceanbiomedical.com/
Investor Relations: https://investors.oceanbiomedical.com/
Phone: 16469082658
The current stock price of OCEA is 0.1 USD. The price decreased by -0.6% in the last trading session.
The exchange symbol of OCEAN BIOMEDICAL INC is OCEA and it is listed on the Nasdaq exchange.
OCEA stock is listed on the Nasdaq exchange.
OCEAN BIOMEDICAL INC (OCEA) has a market capitalization of 3.49M USD. This makes OCEA a Nano Cap stock.
OCEAN BIOMEDICAL INC (OCEA) currently has 9 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
OCEA does not pay a dividend.
OCEAN BIOMEDICAL INC (OCEA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.97).
The outstanding short interest for OCEAN BIOMEDICAL INC (OCEA) is 1.21% of its float. Check the ownership tab for more information on the OCEA short interest.
Over the last trailing twelve months OCEA reported a non-GAAP Earnings per Share(EPS) of -0.97. The EPS increased by 71.42% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -2351.5% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 83% to OCEA. The Buy consensus is the average rating of analysts ratings from 7 analysts.